177 related articles for article (PubMed ID: 9591600)
21. Modification of low-density lipoprotein during radiolabeling with 99mTc using three labeling methods.
Sobal G; Resch U; Tatzber F; Sinzinger H
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):334-43. PubMed ID: 17043631
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of a new leukocyte labeling procedure with 99mTc-HMPAO.
Kelbaek H; Linde J; Nielsen SL
Eur J Nucl Med; 1988; 14(12):621-3. PubMed ID: 3243309
[TBL] [Abstract][Full Text] [Related]
23. Technetium-99m exametazime (99mTc-HMPAO)-labeled white blood cells: a high efficiency multidose procedure.
Ozker K; Collier BD; Hellman RS; Isitman AT; Uzum F; Steffel FG
Eur J Nucl Med; 1995 Feb; 22(2):182-3. PubMed ID: 7758507
[No Abstract] [Full Text] [Related]
24. Technetium-99m labeling of red blood cells: in vitro evaluation of a new approach.
Kelbaek H
J Nucl Med; 1986 Nov; 27(11):1770-3. PubMed ID: 3772511
[TBL] [Abstract][Full Text] [Related]
25. Lymphocyte labeling with technetium-99m-HMPAO: a radiotoxicity study using the micronucleus assay.
Thierens HM; Vral AM; Van Haelst JP; Van de Wiele C; Schelstraete KH; de Ridder LI
J Nucl Med; 1992 Jun; 33(6):1167-74. PubMed ID: 1597733
[TBL] [Abstract][Full Text] [Related]
26. Effect of source and age of sodium pertechnetate Tc 99m on radiochemical purity of technetium Tc 99m exametazime.
Millar AM
Am J Hosp Pharm; 1993 Jan; 50(1):103-6. PubMed ID: 8381258
[TBL] [Abstract][Full Text] [Related]
27. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
Liu M; Wang RF; Zhang CL; Yan P; Yu MM; Di LJ; Liu HJ; Guo FQ
J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
[TBL] [Abstract][Full Text] [Related]
28. Labeling of mixed leukocytes with (99m)Tc-HMPAO causes severe chromosomal aberrations in lymphocytes.
Ak I; Vardereli E; Durak B; Gülbaş Z; Basaran N; Stokkel MP; Pauwels EK
J Nucl Med; 2002 Feb; 43(2):203-6. PubMed ID: 11850485
[TBL] [Abstract][Full Text] [Related]
29. Effects of sequential reagent addition on technetium-99m red blood cell labeling efficiency using the UltraTag kit.
Massler J; Mento C; Shodavaram S; Cason R; Das S; Wang TS; Van Heertum RL
J Nucl Med Technol; 1997 Dec; 25(4):269-71. PubMed ID: 9438928
[TBL] [Abstract][Full Text] [Related]
30. [The radiolabeling property of oligonucleotide with 99mTc using NHS-MAG3 as a chelator].
Zhang C; Tan TZ; Kuang AR; Li YC; Zheng JG; Pan WM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):169-71. PubMed ID: 15071906
[TBL] [Abstract][Full Text] [Related]
31. Relationship of decreased chemotaxis of technetium-99m-HMPAO-labeled lymphocytes to apoptosis.
Van de Wiele C; Philippé J; Van Haelst JP; Van Damme J; Thierens H; Leroux-Roels GE; Dierckx RA
J Nucl Med; 1997 Sep; 38(9):1417-21. PubMed ID: 9293800
[TBL] [Abstract][Full Text] [Related]
32. Stability of the mixture of technetium-99m human serum albumin and lidocaine hydrochloride for clinical application.
Wang YF; Chuang MH; Cham TM; Chung MI
Nucl Med Commun; 2009 Jul; 30(7):494-7. PubMed ID: 19430321
[TBL] [Abstract][Full Text] [Related]
33. Labeling of phagocytes from human blood with 99mTc-sulfur colloid.
English D; Andersen BR
J Nucl Med; 1975 Jan; 16(1):5-10. PubMed ID: 1110404
[TBL] [Abstract][Full Text] [Related]
34. An assessment of factors which influence the effectiveness of the modified in vivo technetium-99m-erythrocyte labeling technique in clinical use.
Kelly MJ; Cowie AR; Antonino A; Barton H; Kalff V
J Nucl Med; 1992 Dec; 33(12):2222-5. PubMed ID: 1460520
[TBL] [Abstract][Full Text] [Related]
35. A simple kit for the preparation of 99mTc-labeled red blood cells.
Smith TD; Richards P
J Nucl Med; 1976 Feb; 17(02):126-32. PubMed ID: 1245874
[TBL] [Abstract][Full Text] [Related]
36. Comparison of in vitro RBC labeling with the UltraTag RBC kit versus in vivo labeling.
Patrick ST; Glowniak JV; Turner FE; Robbins MS; Wolfangel RG
J Nucl Med; 1991 Feb; 32(2):242-4. PubMed ID: 1992026
[TBL] [Abstract][Full Text] [Related]
37. Development and testing of a new disposable sterile device for labelling white blood cells.
Signore A; Glaudemans AW; Malviya G; Lazzeri E; Prandini N; Viglietti AL; De Vries EF; Dierckx RA
Q J Nucl Med Mol Imaging; 2012 Aug; 56(4):400-8. PubMed ID: 23013669
[TBL] [Abstract][Full Text] [Related]
38. 99mTc labeling white blood cells with a simple technique: clinical application.
Gutfilen B; Pellini MP; de Roure e Neder J; de Amarante Júnior JL; Evangelista MG; Fernandes SR; Bernardo-Filho M
Ann Nucl Med; 1994 Feb; 8(1):85-9. PubMed ID: 8204402
[TBL] [Abstract][Full Text] [Related]
39. On the synthesis, isolation, and radiochemical studies for the preparation of in-house kits for 99mTc-meso- and d,l-HMPAO: a few additional observations.
Banerjee S; Samuel G; Kothari K; Sarma HD; Pillai MR
Nucl Med Biol; 1999 Apr; 26(3):327-38. PubMed ID: 10363805
[No Abstract] [Full Text] [Related]
40. 99mTc-HMPAO-labeled liposomes: an investigation into the effects of some formulation factors on labeling efficiency and in vitro stability.
Mirahmadi N; Babaei MH; Vali AM; Daha FJ; Kobarfard F; Dadashzadeh S
Nucl Med Biol; 2008 Apr; 35(3):387-92. PubMed ID: 18355695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
